Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP2759800B2 - Substrate reagent and method of stabilizing detection system - Google Patents
[go: Go Back, main page]

JP2759800B2 - Substrate reagent and method of stabilizing detection system - Google Patents

Substrate reagent and method of stabilizing detection system

Info

Publication number
JP2759800B2
JP2759800B2 JP15520388A JP15520388A JP2759800B2 JP 2759800 B2 JP2759800 B2 JP 2759800B2 JP 15520388 A JP15520388 A JP 15520388A JP 15520388 A JP15520388 A JP 15520388A JP 2759800 B2 JP2759800 B2 JP 2759800B2
Authority
JP
Japan
Prior art keywords
substrate
detection system
added
enzyme
substrate reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP15520388A
Other languages
Japanese (ja)
Other versions
JPH01243998A (en
Inventor
誠彦 山崎
盛人 植村
伸也 吉田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Konica Minolta Inc
Original Assignee
Konica Minolta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Konica Minolta Inc filed Critical Konica Minolta Inc
Priority to JP15520388A priority Critical patent/JP2759800B2/en
Publication of JPH01243998A publication Critical patent/JPH01243998A/en
Application granted granted Critical
Publication of JP2759800B2 publication Critical patent/JP2759800B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は酵素又はその擬似酵素の酸化反応を利用する
検出系の安定化方法及び該検出系に有用である安定な基
質試薬に関する。
Description: TECHNICAL FIELD The present invention relates to a method for stabilizing a detection system utilizing an oxidation reaction of an enzyme or a mimetic enzyme thereof, and a stable substrate reagent useful for the detection system.

〔従来の技術及びその問題点〕 臨床検査、診断分野においては、各種生体内物質の定
性、定量を行うに当り、酵素反応を利用する測定法が広
く用いられている。
[Prior art and its problems] In the field of clinical tests and diagnostics, measurement methods using enzymatic reactions are widely used for qualitative and quantitative determination of various in vivo substances.

例えば抗原抗体反応を利用する酵素免疫測定法におい
ては、標識体として酵素を用いる事により、その活性量
又は活性量の変化を指標として試料中の解析物質の測定
が行われる。標識として用いられる酵素としては経済
性、感度の面から過酸化酵素(ペルオキシダーゼ)が最
も広く使用されている。また、ある種の生体成分、例え
ばコレステロール、グルコース、モノアミン等の測定は
対応する酸化酵素であるコレステロールオキシダーゼ、
グルコースオキシダーゼ、モノアミンオキシダーゼ等を
作用させる事により生成する過酸化水素量を過酸化酵素
を用いて定量する事により行われる。
For example, in an enzyme immunoassay utilizing an antigen-antibody reaction, an enzyme is used as a label, and the amount of an analyte or a substance to be analyzed in a sample is measured using the amount of activity or a change in the amount of activity as an index. As an enzyme used as a label, peroxidase (peroxidase) is most widely used in terms of economy and sensitivity. In addition, measurement of certain biological components, for example, cholesterol, glucose, monoamine, etc., is performed by cholesterol oxidase, a corresponding oxidase,
It is carried out by quantifying the amount of hydrogen peroxide generated by the action of glucose oxidase, monoamine oxidase or the like using a peroxidase.

過酸化酵素の活性測定、過酸化水素の定量には、過酸
化酵素、過酸化水素等の過酸化物質及び基質からなる検
出系に於てその酵素反応が利用される。酵素反応は一般
に水系溶媒中で行われ、過酸化酵素や過酸化物質の量に
応じ基質が酸化されその程度を解析することによって測
定が行われる。
For the measurement of the activity of peroxidase and the quantification of hydrogen peroxide, the enzyme reaction is used in a detection system comprising a peroxidase, a peroxide substance such as hydrogen peroxide and a substrate. The enzymatic reaction is generally performed in an aqueous solvent, and the measurement is performed by analyzing the degree to which the substrate is oxidized according to the amount of the peroxidase or the peroxidant.

使用される基質は過酸化酵素による酸化作用により解
析手段(一般的には物質)を与える化合物であり、通常
呈色色素を生成する芳香族アミン化合物やフェノール系
化合物などが知られている。芳香族アミン化合物、例え
ばo−フェニレンジアミンは高い感度を得る事ができ、
最も広く用いられる。
The substrate to be used is a compound that provides an analysis means (generally, a substance) by an oxidizing action of a peroxidase, and an aromatic amine compound or a phenolic compound which usually produces a color dye is known. Aromatic amine compounds, such as o-phenylenediamine, can obtain high sensitivity,
Most widely used.

しかしながら、o−フェニレンジアミンを含め、一般
に基質は安定性が十分でない場合が多く、光、酸素等に
より非酵素的に酸化を受け、検出系において高いバック
グランド濃度を生じたり、経時的に検出値が大きい方へ
振れるなど、この不安定性が実際の測定における測定誤
差の要因となっていた。それ故、暗所における取扱いや
基質含有試薬液に調製後から使用までの時間制限等が課
され、基質、その基質を用いる検出系の安定化方法が強
く要望されていた。
However, in general, the substrate, including o-phenylenediamine, is often not sufficiently stable, and is non-enzymatically oxidized by light, oxygen, etc., resulting in a high background concentration in the detection system or the detection value over time. This instability caused a measurement error in the actual measurement, such as swinging to a larger value. Therefore, handling in a dark place, time limitation from preparation to use of a substrate-containing reagent solution, and the like are imposed, and there has been a strong demand for a method of stabilizing a substrate and a detection system using the substrate.

〔発明の目的〕[Object of the invention]

前記の情況に照し、本発明の目的は非酵素的酸化が抑
えられた安定な基質試薬及び検出系の安定化方法の提供
にある。
In view of the above circumstances, an object of the present invention is to provide a stable substrate reagent in which non-enzymatic oxidation is suppressed and a method for stabilizing a detection system.

〔発明の構成〕[Configuration of the invention]

前記した本発明の目的は、酸化作用を有する酵素又は
その擬似酵素及び酸化されることにより解析手段を与え
る基質を用いる検出系に於て3個以上の燐オキソ酸単位
からなる縮合燐オキソ酸誘導体を含有する検出系並びに
前記基質と前記縮合燐オキソ酸誘導体を含有する基質試
薬によって達成される。
An object of the present invention is to provide a condensed phosphorus oxo acid derivative comprising three or more phosphorus oxo acid units in a detection system using an enzyme having an oxidizing action or a mimetic enzyme thereof and a substrate which provides analysis means by being oxidized. And a substrate reagent containing the substrate and the condensed phosphorus oxo acid derivative.

尚前記本発明の基質試薬並びに検出系の安定化方法の
態様に於て、前記基質は呈色色素、発光物質または蛍光
物質を与えるものが好ましく、芳香族アミン化合物、就
中o−フェニレンジアミン、o−ジアニシジン、3,3′,
5,5′−テトラメチルベンジジンであることが好まし
い。
In the embodiment of the method for stabilizing the substrate reagent and the detection system of the present invention, the substrate preferably provides a coloring dye, a luminescent substance or a fluorescent substance, and is preferably an aromatic amine compound, especially o-phenylenediamine, o-dianisidine, 3,3 ',
Preferably it is 5,5'-tetramethylbenzidine.

又、前記酵素またはその疑似酵素は過酸化酵素又はそ
の過酸化疑似酵素であることが好ましい。ここで擬酵素
とは先記する酵素に着目する作用効果が同一と看做され
る物質をいう。
Preferably, the enzyme or its pseudo-enzyme is a peroxidase or its peroxidase-like enzyme. Here, the pseudo-enzyme refers to a substance that is considered to have the same effect as the above-mentioned enzyme.

又前記の縮合燐オキソ酸誘導体は3個以上の酸化数5
の燐オキソ酸単位からなるものが好ましく、また縮合燐
オキソ酸又は縮合燐オキソ酸の一部もしくは全部が塩と
なった化合物又はそれらの混合物が好ましく、更にポリ
燐酸アルカリ金属塩、メタ燐酸アルカリ金属塩またはウ
ルトラ燐酸アルカリ金属塩が好ましい。
Further, the above-mentioned condensed phosphorus oxo acid derivative has an oxidation number of 3 or more and 5 or more.
Preferred are those comprising a phosphorus oxo acid unit of the formula (I), and preferred are condensed phosphorus oxo acids or compounds in which some or all of the condensed phosphorus oxo acids are salts or mixtures thereof. Further, alkali metal polyphosphates, alkali metal metaphosphates Salts or alkali metal ultraphosphates are preferred.

次に本発明を詳しく説明する。 Next, the present invention will be described in detail.

本発明に係る縮合燐オキソ酸誘導体は3個以上の燐オ
キソ酸単位から成るものであればよいが、燐オキソ酸単
位が3〜6個結合したものが好ましい。
The condensed phosphorus oxo acid derivative according to the present invention may be composed of three or more phosphorus oxo acid units, and preferably has three to six phosphorus oxo acid units bonded.

また各々単位燐オキソ酸は酸化数2〜5のいずれの燐
酸でも良いがすべての単位燐オキソ酸が酸化数5の燐酸
である場合が好ましい。
Further, each unit phosphorous oxoacid may be any phosphoric acid having an oxidation number of 2 to 5, but it is preferable that all the unit phosphorous oxoacids be phosphoric acid having an oxidation number of 5.

本発明に係る縮合燐オキソ酸誘導体は、単位燐オキソ
酸の結合様式により種々の構造、即ち鎖状構造、環状構
造もしくは架橋構造更にそれら構造の共存した構造を有
するものを含み、ポリ燐酸誘導体、メタ燐酸誘導体もし
くはウルトラ燐酸誘導体、それら結合の共存した誘導体
が好ましい。
The condensed phosphorus oxo acid derivatives according to the present invention include those having various structures depending on the bonding mode of the unit phosphorus oxo acid, that is, those having a chain structure, a cyclic structure or a cross-linked structure, and a structure having a coexistence of those structures. A metaphosphoric acid derivative or an ultraphosphoric acid derivative, or a derivative coexisting with a bond thereof is preferable.

前記誘導体の例としては縮合燐オキソ酸又は縮合燐オ
キソ酸無機塩例えばナトリウム,カリウム,リチウム等
のアルカリ金属塩、マグネシウム,カルシウム等のアル
カリ土類金属塩、アンモニウム塩、又は縮合燐オキソ酸
有機塩例えばピリジウム塩等が挙げられる。又、縮合燐
オキソ酸エステル,縮合燐オキソ酸アミド、燐に直接有
機置換基が結合したもの等の有機燐オキソ酸誘導体が挙
げられる。又一分子中にフリーの酸単位や塩を作った単
位や有機置換基が結合した単位が混在していても良く、
縮合燐オキソ酸又は縮合燐オキソ酸の一部もしくは全部
が塩になったものが好ましい。
Examples of the derivative include condensed phosphorus oxoacids or condensed phosphorus oxoacid inorganic salts, for example, alkali metal salts such as sodium, potassium and lithium, alkaline earth metal salts such as magnesium and calcium, ammonium salts, and condensed phosphorus oxoacid organic salts. For example, pyridium salts and the like can be mentioned. Also, organic phosphorus oxo acid derivatives such as condensed phosphorus oxo acid ester, condensed phosphorus oxo acid amide, and those in which an organic substituent is directly bonded to phosphorus can be used. In addition, a free acid unit, a unit forming a salt, and a unit to which an organic substituent is bonded may be mixed in one molecule,
It is preferred that the condensed phosphorus oxo acid or a part or all of the condensed phosphorus oxo acid be a salt.

更に本発明においては2種以上の縮合燐オキソ酸誘導
体が混合して用いられてもよい。
Further, in the present invention, two or more kinds of condensed phosphorus oxo acid derivatives may be used as a mixture.

次に本発明に係る縮合燐オキソ酸誘導体の具体例を例
示するがこれらに限定されるものではない。
Next, specific examples of the condensed phosphorus oxo acid derivative according to the present invention will be described, but the present invention is not limited thereto.

尚アルキル置換体に於ては炭素原子数1〜8個のアル
キル基が好ましい。
In the alkyl substituent, an alkyl group having 1 to 8 carbon atoms is preferable.

トリポリ燐酸 トリポリ燐酸五ナトリウム トリポリ燐酸三ナトリウム トリポリ燐酸五カリウム トリポリ燐酸五アンモニウム テトラポリ燐酸 テトラポリ燐酸六ナトリウム ペンタポリ燐酸 ペンタポリ燐酸七ナトリウム ヘキサポリ燐酸 ヘキサポリ燐酸八ナトリウム オクタポリ燐酸十ナトリウム トリメタ燐酸 トリメタ燐酸三ナトリウム トリメタ燐酸三カリウム トリメタ燐酸三アンモニウム テトラメタ燐酸 テトラメタ燐酸四ナトリウム テトラメタ燐酸四カリウム ペンタメタ燐酸五ナトリウム ヘキサメタ燐酸 ヘキサメタ燐酸六ナトリウム グラハム(graham)塩 テトラウルトラ燐酸二ナトリウム モノアルキルトリポリ燐酸 モノアルキルトリポリ燐酸四ナトリウム トリアルキルトリポリ燐酸 トリアルキルトリポリ燐酸二ナトリウム ペンタアルキルトリポリ燐酸 モノアルキルテトラポリ燐酸 テトラアルキルテトラポリ燐酸 モノアルキルトリメタ燐酸二ナトリウム トリアルキルトリメタ燐酸 トリフェニルトリポリ燐酸 本発明に係る基質は、酸化されることにより解析手段
を与える。例えば呈色色素、発光物質或いは蛍光物質を
生成する化合物であれば良く、一般に過酸化酵素、過酸
化水素の酵素反応を利用する検出系に用いられる基質が
含まれる。代表的なものとしては芳香族アミン化合物や
フェノール系化合物などが挙げられる。
Tripolyphosphate pentasodium tripolyphosphate trisodium tripolyphosphate pentapotassium tripolyphosphate pentaammonium tripolyphosphate tetrasodium tetrapolyphosphate hexasodium pentapolyphosphate pentasodium pentapolyphosphate hexasodium hexapolyphosphate hexasodium octapolyphosphate octasodium pentapolyphosphate trisodium trimetaphosphate trisodium trimetaphosphate trimetaphosphate Triammonium trimetaphosphate tetrametaphosphate tetrasodium tetrametaphosphate tetrapotassium tetrametaphosphate pentasodium pentametaphosphate hexametaphosphate hexasodium hexametaphosphate Graham salt Disodium tripolyphosphate pentaalkyl Rutripolyphosphoric acid Monoalkyltetrapolyphosphoric acid Tetraalkyltetrapolyphosphoric acid Monoalkyltrimetaphosphate disodium Trialkyltrimetaphosphate Triphenyltripolyphosphoric acid The substrate according to the present invention provides an analytical means by being oxidized. For example, a compound that produces a coloring dye, a luminescent substance or a fluorescent substance may be used, and generally includes a substrate used in a detection system utilizing an enzymatic reaction of a peroxidase and hydrogen peroxide. Representative examples include aromatic amine compounds and phenol compounds.

具体例としては、o−フェニレンジアミン,m−フェニ
レンジアミン,p−フェニレンジアミン,ベンジジン,o−
ジアニジジン,o−トリジン,3,3′,5,5′−テトラメチル
ベンジジン,ジアミノベンジジン,ジカルボキシジン,
2,2′−アジノ−ビス(3−エチルベンゾチアゾリン−
6−スルホン酸),3−アミノ−9−エチルカルバゾー
ル、4−クロル−1−ナフトール,ピロガロール,4−ア
ミノ−アンチピリン,4−アミノ−N,N−ジメチルアニリ
ン,4−アミノアンチピリンとジメチルアニリン,4−アミ
ノアンチピリンとジメチルアニリン混合物、4−アミノ
アンチピリンとジメチルアナニリン混合物,4−アミノア
セチピリンとフェノールの混合物、ピロガロールとp−
フェニレンジアミンの混合物、4−クロル−1−ナフト
ールとN−エチル−N′−ヒドロキシエチル−3−メチ
ル−4−アミノアニリンの混合物、5−アミノサリチル
酸,3−メチル−2−ベンゾチアゾリノンヒドラゾンとジ
メチルアニリンの混合物、4−ヒドロキシフェニル酢
酸,3−(4−ヒドロキシフェニル)プロピオン酸,ルミ
ノール等が挙げられ、またこれらの塩も有用である。
Specific examples include o-phenylenediamine, m-phenylenediamine, p-phenylenediamine, benzidine, and o-phenylenediamine.
Dianididine, o-tolidine, 3,3 ', 5,5'-tetramethylbenzidine, diaminobenzidine, dicarboxyzine,
2,2'-azino-bis (3-ethylbenzothiazoline-
6-sulfonic acid), 3-amino-9-ethylcarbazole, 4-chloro-1-naphthol, pyrogallol, 4-amino-antipyrine, 4-amino-N, N-dimethylaniline, 4-aminoantipyrine and dimethylaniline, 4-aminoantipyrine and dimethylaniline mixture, 4-aminoantipyrine and dimethylananiline mixture, 4-aminoacetipirin and phenol mixture, pyrogallol and p-
A mixture of phenylenediamine, a mixture of 4-chloro-1-naphthol and N-ethyl-N'-hydroxyethyl-3-methyl-4-aminoaniline, 5-aminosalicylic acid, 3-methyl-2-benzothiazolinone hydrazone And dimethylaniline, 4-hydroxyphenylacetic acid, 3- (4-hydroxyphenyl) propionic acid, luminol and the like, and salts thereof are also useful.

本発明に係る酵素又は擬似酵素としては、基質を酸化
し解析手段を与える反応を触媒するものであれば特に限
定されないが、過酸化酵素又は疑似過酸化酵素が好まし
い。過酸化酵素又は疑似過酸化酵素による酸化反応には
過酸化物質が必要とされる。過酸化物質としてはいずれ
の過酸化物質例えば有機過酸化物質であっても良いが、
過酸化水素が好ましい。
The enzyme or pseudoenzyme according to the present invention is not particularly limited as long as it catalyzes a reaction that oxidizes a substrate and provides an analysis means, but a peroxidase or a pseudoperoxidase is preferable. A peroxidant is required for the oxidation reaction by peroxidase or pseudoperoxidase. The peroxide may be any peroxide, such as an organic peroxide,
Hydrogen peroxide is preferred.

過酸化酵素としては例えばホースラディッシュペルオ
キシダーゼ,ラクトペルオキシダーゼ,ミエロペルオキ
シダーゼ,グルタチオンペルオキシダーゼ,チトクロー
ムCペルオキシダーゼ等が使用可能であり、また擬似過
酸化酵素としては、例えばヘモグロビンや鉄,金,銀等
の金属及び金属化合物が使用可能である。
As the peroxidase, for example, horseradish peroxidase, lactoperoxidase, myeloperoxidase, glutathione peroxidase, cytochrome C peroxidase, etc. can be used. As the pseudoperoxidase, for example, metals such as hemoglobin, iron, gold, silver and the like, Compounds can be used.

本発明の基質試薬には少くとも、酸化されることによ
り解析手段を与える基質及び3個以上の燐オキソ酸単位
より成る縮合燐オキソ酸誘導体が含まれていれば良く、
また、過酸化水素等の過酸化物質又は過酸化酵素が含ま
れても良く、更に、必要に応じてその他の物質例えば安
定化剤が含まれていてもよい。
It is sufficient that the substrate reagent of the present invention contains at least a substrate that provides an analysis means by being oxidized and a condensed phosphorus oxoacid derivative composed of three or more phosphorus oxoacid units.
In addition, a peroxide substance such as hydrogen peroxide or a peroxidase may be contained, and other substances such as a stabilizer may be contained as necessary.

本発明の基質試薬としては、固体状、粉末状、溶液状
など種々の形態のものが含まれ、酵素反応を利用した検
出系にそのまま使用可能な溶液状態のもの(以下基質試
薬試液と称する)も含まれる。必要であれば、これらは
適当な操作、例えば溶媒への溶解等により検出系に使用
可能な溶液状の基質試薬試液に調製が可能である。
The substrate reagent of the present invention includes various forms such as solid, powder, and solution, and is in the form of a solution that can be used as it is in a detection system utilizing an enzyme reaction (hereinafter referred to as a substrate reagent reagent). Is also included. If necessary, these can be prepared into a solution of the substrate reagent usable in the detection system by a suitable operation such as dissolution in a solvent.

本発明に係る検出系は、前記酵素又はその擬似酵素に
より前記基質の酸化反応を行わせ、その程度を例えば光
学的手段により検出する系であり、結果の解析により目
的の情報、例えば酵素活性に対応した試料中の解析物質
量を得る事ができる。一般に、その酵素又は擬似酵素の
酸化反応は基質を溶解した溶液中にて行われる。
The detection system according to the present invention is a system in which the substrate or the mimetic enzyme thereof is used to oxidize the substrate, and the degree of the oxidation is detected, for example, by optical means. It is possible to obtain the amount of the analytical substance in the corresponding sample. Generally, the oxidation reaction of the enzyme or mimetic enzyme is performed in a solution in which the substrate is dissolved.

基質試薬試液又は検出系に用いる溶媒としては一般に
は水系溶媒が好ましいが酵素的酸化反応を極端に阻害す
るものでなければ、有機溶媒又は有機溶媒と水系溶媒の
混合溶媒であってもよい。溶媒は酵素反応に適当なpH値
にあることが望ましく、通常用いられる緩衝剤により調
製することが好ましい。過酸化酵素を用いる場合は、pH
3〜9が好ましい。
In general, an aqueous solvent is preferable as a solvent used for the substrate reagent reagent or the detection system, but an organic solvent or a mixed solvent of an organic solvent and an aqueous solvent may be used as long as it does not extremely inhibit the enzymatic oxidation reaction. The solvent preferably has a pH value suitable for the enzymatic reaction, and is preferably prepared with a commonly used buffer. When using peroxidase, pH
3 to 9 are preferred.

尚、基質試薬試液を調製するための溶媒への各成分の
添加順序は特に限定されることはない。
The order of adding each component to the solvent for preparing the substrate reagent solution is not particularly limited.

本発明の基質試薬の1つの形態である基質試薬試液又
は検出系において含有される本発明に係る縮合燐オキソ
酸誘導体の濃度は酵素反応における阻害の程度と非酵素
的酸化の抑制度を考慮し決定され、その種類によって多
少異なるが、通常0.01〜1000mMであり、好ましくは0.1
〜300mMである。より好ましくは例えばトリポリ燐酸五
カリウムの場合は約0.3〜約50mM、テトラポリ燐酸六ナ
トリウムの場合は約0.3〜50mM、テトラウルトラ燐酸二
ナトリウムの場合は約0.3〜約50mM、ヘキサメタ燐酸六
ナトリウムの場合は約1〜100mMである。又、本発明に
係る縮合燐オキソ酸誘導体は緩衝能を有しており、適当
な酸、塩基を加え任意のpHに調整することにより基質試
薬試液の緩衝剤としても使用可能である。又、基質の濃
度は0.1〜100mMが適当である。
The concentration of the condensed phosphorus oxoacid derivative according to the present invention contained in the substrate reagent reagent solution or the detection system, which is one form of the substrate reagent of the present invention, takes into account the degree of inhibition in the enzymatic reaction and the degree of inhibition of non-enzymatic oxidation. It is determined, and varies slightly depending on the type, but is usually 0.01 to 1000 mM, preferably 0.1
~ 300mM. More preferably, for example, about 0.3 to about 50 mM for pentapotassium tripolyphosphate, about 0.3 to 50 mM for hexasodium tetrapolyphosphate, about 0.3 to about 50 mM for disodium tetraultraphosphate, and hexasodium hexametaphosphate. About 1 to 100 mM. Further, the condensed phosphorus oxoacid derivative according to the present invention has a buffering ability, and can be used as a buffer for a substrate reagent test solution by adjusting the pH to an appropriate value by adding an appropriate acid or base. Further, the concentration of the substrate is suitably 0.1 to 100 mM.

本発明の基質試薬が特に有用に適用され、本発明の安
定化方法が特に有効な検出系は、過酸化物質及び過酸化
酵素及び酸化作用により光学的に検出可能な物質を生成
する基質から成る検出系であり、本発明により過酸化水
素量もしくは過酸化酵素活性の安定で正確な測定が可能
となる。
A detection system in which the substrate reagent of the present invention is particularly usefully applied, and in which the stabilization method of the present invention is particularly effective, comprises a peroxidant, a peroxidase, and a substrate that produces an optically detectable substance by an oxidizing action. It is a detection system, and the present invention enables stable and accurate measurement of the amount of hydrogen peroxide or the activity of peroxidase.

この場合も、基質試薬試液調製時の溶媒への各成分の
溶媒への添加の順序は特に限定されない。例えば過酸化
酵素特定のための基質試薬試液の調製については、縮合
燐オキソ酸誘導体が過酸化物質特に過酸化水素の分解を
抑制する効果を有することから、過酸化水素の保存安定
性の有利さを考慮し、例えば、まず溶媒中に過酸化水素
と縮合燐オキソ酸誘導体を溶解したものを保存液とし、
これに検出系への使用直前に基質を加えることにより、
目的の基質試薬試液を調製することも可能である。
Also in this case, the order of adding each component to the solvent at the time of preparing the substrate reagent test solution is not particularly limited. For example, regarding the preparation of a substrate reagent reagent solution for identifying peroxidase, the advantage of storage stability of hydrogen peroxide is that the condensed phosphorus oxoacid derivative has the effect of suppressing the decomposition of peroxides, particularly hydrogen peroxide. Considering, for example, first, a solution in which hydrogen peroxide and a condensed phosphorus oxo acid derivative are dissolved in a solvent is used as a storage solution,
By adding the substrate to this just before use in the detection system,
It is also possible to prepare a target substrate reagent reagent solution.

例えば検出系は以下のごとく行なわれる。即ち0.1mM
〜100mMの濃度の基質及び安定化剤として0.01〜1000m
M、好ましくは0.01〜300mMの濃度の本発明の縮合燐オキ
ソ酸誘導体を含有させたpH3〜9の範囲の任意のpHの緩
衝液を調製する。過酸化酵素活性を測定する場合は更に
過酸化水素を、過酸化水素量を測定する場合は更に過酸
化酵素を一定量含有せしめ、基質試薬試液を調製する。
基質試薬試液と試料とを混合し、2〜50℃の温度で酵素
反応を行わせ一定時間後、硫酸等の酸、弗素化合物、ア
ジ化ソーダなどを加え反応を停止する。試料中の過酸化
酸素活性又は過酸化水素量に応じて基質が酸化され、そ
の結果生成した物質を、光学的に検出する。
For example, the detection system is performed as follows. That is, 0.1 mM
Substrate at a concentration of ~ 100mM and 0.01 ~ 1000m as stabilizer
A buffer having an arbitrary pH in the range of pH 3 to 9 containing the condensed phosphorus oxoacid derivative of the present invention at a concentration of M, preferably 0.01 to 300 mM is prepared. To measure the activity of peroxidase, hydrogen peroxide is further added, and to measure the amount of hydrogen peroxide, a certain amount of peroxidase is further added to prepare a substrate reagent test solution.
The substrate reagent reagent solution and the sample are mixed, an enzyme reaction is performed at a temperature of 2 to 50 ° C., and after a certain period of time, an acid such as sulfuric acid, a fluorine compound, sodium azide, and the like are added to stop the reaction. The substrate is oxidized according to the oxygen peroxide activity or the amount of hydrogen peroxide in the sample, and the resulting substance is optically detected.

生成物質が例えば呈色色素であれば最大吸収波長にお
ける吸光度を測定し、既知量の過酸化酵素又は過酸化水
素について同様な操作を行って作成した検量線との対比
を行うことにより定量測定が可能となる。
If the produced substance is a coloring dye, for example, quantitative measurement can be performed by measuring the absorbance at the maximum absorption wavelength and comparing with a calibration curve prepared by performing the same operation on a known amount of peroxidase or hydrogen peroxide. It becomes possible.

本発明は任意の酵素免疫測定法、例えば均一系測定法
又は均一系測定法、一抗体法又は二抗体法、エンザイム
リンクトイムノアブソーベントアッセイ又はエンザイム
イムノスティニング等いづれの一般的な測定法にも適用
可能である。
The present invention relates to any enzyme immunoassay, for example, a homogeneous assay or a homogeneous assay, a one-antibody assay or a two-antibody assay, an enzyme-linked immunoabsorbent assay or an enzyme immunostaining. Is also applicable.

本発明の方法を用いた検出系又は本発明の基質試薬を
適用した検出系では、酵素反応が阻害されることなく基
質の非酵素的酸化反応が抑制され、きわめて安定化され
る。また、酵素反応停止後の非酵素的酸化反応による生
成物質の増加も抑制され、正確な値が保持される。
In the detection system using the method of the present invention or the detection system to which the substrate reagent of the present invention is applied, the non-enzymatic oxidation reaction of the substrate is suppressed without inhibiting the enzymatic reaction, and is extremely stabilized. In addition, an increase in the amount of product due to the non-enzymatic oxidation reaction after the stop of the enzymatic reaction is suppressed, and an accurate value is maintained.

本発明により、酵素活性又は過酸化水素量さらにはこ
れらに対応する解析対象物質量の測定を極めて精度の高
いものとすることが可能となった。
According to the present invention, it has become possible to make the measurement of the enzyme activity or the amount of hydrogen peroxide and also the amount of the analysis target substance corresponding thereto extremely accurate.

〔実施例〕〔Example〕

以下、実施例により本発明を更に詳細に説明するが、
これらの実施例は本発明の範囲を何ら制限するものでは
ない。
Hereinafter, the present invention will be described in more detail by examples,
These examples do not limit the scope of the invention in any way.

実施例1 o−フェニレンジアミンを3mg/mlの濃度で含む50mMく
えん酸−100mM燐酸緩衝液(pH4.9)にトリポリ燐酸五ナ
トリウムを添加したもの及び無添加のものを調製し、さ
らに過酸化水素を0.02%となる様に加え、pHがシフトし
たものについては塩酸又は水酸化ナトリウムでpHを4.9
に調製し基質試薬試液とした。基質試薬試液を0.5ml宛
2本ずつに分注し、一方には0.5μg/mlの濃度のホース
ラディッシュペルオキシダーゼ結合ヤギ抗マウスイムノ
グロブリン抗体(カッペル社製)10μを添加し、他方
には添加しなかった。それぞれを37℃の暗所にて30分間
反応させ、次いでこの混合物に1NH2SO42mlを加え反応を
停止させ、492nmにおける吸光度を測定した。その結果
を表1に示す。
Example 1 A 50 mM citric acid-100 mM phosphate buffer (pH 4.9) containing o-phenylenediamine at a concentration of 3 mg / ml was prepared by adding pentasodium tripolyphosphate and without adding pentasodium tripolyphosphate. To a concentration of 0.02%. If the pH is shifted, the pH is adjusted to 4.9 with hydrochloric acid or sodium hydroxide.
And used as a substrate reagent test solution. The substrate reagent TS was dispensed into two 0.5 ml portions, one of which was added 10 μl of a horseradish peroxidase-conjugated goat anti-mouse immunoglobulin antibody (manufactured by Kappel) at a concentration of 0.5 μg / ml, and the other was added. Did not. Each was allowed to react in a dark place at 37 ° C. for 30 minutes. Then, 2 ml of 1NH 2 SO 4 was added to the mixture to stop the reaction, and the absorbance at 492 nm was measured. Table 1 shows the results.

尚酵素活性値は酵素結合抗体添加の場合の値と無添加
の場合の値の差によって表した。
The enzyme activity value was represented by the difference between the value when the enzyme-conjugated antibody was added and the value when no enzyme-conjugated antibody was added.

表1よりトリポリ燐酸五ナトリウムを0.3mMから50mM
の範囲で添加することにより、酵素反応がほとんど阻害
されることなく非酵素的酸化反応が顕著に抑制され検出
系が安定する事が明らかである。
From Table 1, pentasodium tripolyphosphate was added from 0.3 mM to 50 mM.
It is evident that the addition within the above range significantly inhibits the non-enzymatic oxidation reaction without substantially inhibiting the enzymatic reaction and stabilizes the detection system.

実施例2 添加する縮合燐オキソ酸誘導体としてトリポリ燐酸五
ナトリウムの代わりにトリポリ燐酸五カリウムを用いた
ほかは実施例1と同様に行なった。その結果を表2に示
す。
Example 2 Example 2 was repeated except that pentapotassium tripolyphosphate was used instead of pentasodium tripolyphosphate as a condensed phosphorus oxoacid derivative to be added. Table 2 shows the results.

表2より、トリポリ燐酸五カリウムを約0.3〜50mMの
範囲で添加することにより酵素反応がほとんど阻害され
ることなく、非酵素的酸化反応が顕著に抑制され、検出
系が安定することが明らかである。
From Table 2, it is clear that the addition of pentapotassium tripolyphosphate in the range of about 0.3 to 50 mM hardly inhibits the enzymatic reaction, significantly suppresses the non-enzymatic oxidation reaction, and stabilizes the detection system. is there.

実施例3 次に添加する縮合燐オキソ酸誘導体としてトリポリ燐
酸五ナトリウムの代わりにテトラポリ燐酸六ナトリウム
を用いたほかは実施例1と同様に行った。
Example 3 The procedure of Example 1 was repeated, except that hexasodium tetrapolyphosphate was used instead of pentasodium tripolyphosphate as the condensed phosphorus oxoacid derivative to be added.

その結果を表3に示す。 Table 3 shows the results.

表3よりテトラポリ燐酸六ナトリウムを約0.3〜50mM
の範囲で添加することにより酵素反応がほとんど阻害さ
れることなく非酵素的酸化反応が顕著に抑制され検出系
が安定することが明らかである。
Table 3 shows that hexapolysodium tetrapolyphosphate was added at about 0.3 to 50 mM.
It is evident that the addition within the above range significantly suppresses the non-enzymatic oxidation reaction without substantially inhibiting the enzymatic reaction, and stabilizes the detection system.

実施例4 添加する縮合燐オキソ酸誘導体としてトリポリ燐酸五
ナトリウムの代わりにヘキサメタ燐酸六ナトリウムを用
いたほかは実施例1と同様の測定を行った。
Example 4 The same measurement as in Example 1 was performed except that hexasodium hexametaphosphate was used instead of pentasodium tripolyphosphate as a condensed phosphorus oxoacid derivative to be added.

結果を表4に示す。 Table 4 shows the results.

表4よりヘキサメタ燐酸六ナトリウムを約1〜約100m
Mの範囲で添加することにより酵素反応がほとんど阻害
されることなく非酵素的酸化反応が顕著に抑制され検出
系が安定することが明らかである。
From Table 4, hexasodium hexametaphosphate is about 1 to about 100m
It is clear that the addition in the range of M significantly suppresses the non-enzymatic oxidation reaction with almost no inhibition of the enzymatic reaction and stabilizes the detection system.

実施例5 添加する縮合燐オキソ酸誘導体としてトリポリ燐酸五
ナトリウムの代わりにテトラウルトラ燐酸二ナトリウム
(分子式:Na2P4O11)を用いたほかは実施例1と同様に
行った。その結果を表5に示す。
Example 5 The same operation as in Example 1 was carried out except that disodium tetraultraphosphate (molecular formula: Na 2 P 4 O 11 ) was used instead of pentasodium tripolyphosphate as a condensed phosphorus oxoacid derivative to be added. Table 5 shows the results.

表5より、テトラウルトラ燐酸二ナトリウムを約1〜
約50mMの範囲で添加することにより酸素反応がほとんど
阻害されることなく、非酸素的酸化反応が顕著に抑制さ
れ、検出系が安定することが明らかである。
From Table 5, the disodium tetraultraphosphate was added to about 1 to
It is clear that the addition in the range of about 50 mM significantly suppresses the non-oxygenous oxidation reaction without substantially inhibiting the oxygen reaction, and stabilizes the detection system.

実施例6 オルトフェニレンジアミンが3mg/mlの濃度、過酸化水
素が0.02%となる様に調整した50mMくえん酸−100mM燐
オキソ酸緩衝液(pH4.9)に各種縮合燐酸誘導体を添加
したもの及び無添加のものを調整し、基質試薬試液とし
て。0.5mlずつ分注し各種条件下にて放置した後、1NH2S
O42mlを加え、492nmの吸光度を測定した。結果を表6に
示す。
Example 6 Various condensed phosphoric acid derivatives were added to a 50 mM citric acid-100 mM phosphoric oxoacid buffer (pH 4.9) adjusted to a concentration of orthophenylenediamine of 3 mg / ml and a concentration of hydrogen peroxide of 0.02%, and Adjust the additive-free one, and use it as a substrate reagent TS. After dispensing 0.5 ml each and leaving under various conditions, 1NH 2 S
2 ml of O 4 was added, and the absorbance at 492 nm was measured. Table 6 shows the results.

表6よりトリポリ燐酸五ナトリウム、トリポリ燐酸五
カリウム、テトラポリ燐酸六ナトリウム、ヘキサメタ燐
酸六ナトリウム、テトラウルトラ燐酸二ナトリウム等縮
合燐オキソ酸誘導体を含有せしめることにより非酵素的
酸化反応が抑制され、経時安定性が増加していることが
明らかである。
As shown in Table 6, non-enzymatic oxidation reaction is suppressed by adding a condensed phosphorus oxo acid derivative such as pentasodium tripolyphosphate, pentapotassium tripolyphosphate, hexasodium tetrapolyphosphate, hexasodium hexametaphosphate, disodium tetraultraphosphate, and the aging is stable. It is clear that the sex is increasing.

実施例7 実施例6と同様に基質試薬試液を調整し、4℃暗所に
て24時間放置した後0.5μg/mlの濃度のホースラディッ
シュ結合ヤギ坑マウスイムノグロブリン抗体(カッペル
社製)10μを加え37℃にて30分間反応させた。1NH2SO
42mlを加え反応を停止させ、492nmにおける吸光度を測
定し、縮合燐オキソ酸誘導体無添加の場合を対照とし、
相対酵素活性を求めた。
Example 7 A substrate reagent TS was prepared in the same manner as in Example 6, allowed to stand in a dark place at 4 ° C. for 24 hours, and then 10 μl of a horseradish-bound goat anti-mouse immunoglobulin antibody (manufactured by Kappel) having a concentration of 0.5 μg / ml was prepared. The reaction was carried out at 37 ° C. for 30 minutes. 1NH 2 SO
4 Add 2 ml to stop the reaction, measure the absorbance at 492 nm, the case of no addition of the condensed phosphorus oxo acid derivative as a control,
The relative enzyme activity was determined.

その結果を表7に示す。 Table 7 shows the results.

表7より本発明の縮合燐オキソ酸誘導体を含有した基
質試薬試液は経時的な保存においても酵素反応を阻害す
ることなく安定なことが示された。
Table 7 shows that the substrate reagent test solution containing the condensed phosphorus oxoacid derivative of the present invention is stable even during storage over time without inhibiting the enzyme reaction.

実施例8 実施例1〜5にて、硫酸を加え反応を停止した基質試
薬試液について、室温暗所にて24時間放置した後492nm
の吸光度を測定し停止直後の場合を対照として相対値を
求めた。その結果を表8に示す。
Example 8 In Examples 1 to 5, the substrate reagent solution in which sulfuric acid was added to stop the reaction was left at room temperature in a dark place for 24 hours, and then 492 nm
Was measured, and the relative value was determined using the case immediately after the stop as a control. Table 8 shows the results.

表8より酵素反応を停止させた後の基質試薬試液の安
定性が、縮合燐オキソ硫酸誘導体を含有することにより
向上することが明らかである。
From Table 8, it is clear that the stability of the substrate reagent TS after stopping the enzyme reaction is improved by containing the condensed phosphorus oxosulfate derivative.

実施例9 o−フェニレンジアミン3mg/mlの濃度で含む100mM燐
酸緩衝液(pH5.0)に各種縮合燐オキソ酸誘導体を含有
したもの及び含有しないものを調製し、更に過酸化水素
を0.01%となる様に加え基質試薬試液とした。基質試薬
試液を0.5ml宛2本ずつに分注し、一方には0.1μg/mlの
濃度のホースラディッシュペルオキシダーゼ結合ヤギ抗
マウスイムノグロブリン抗体(カッペル社製)20μを
添加し、他方には添加しなかった。それぞれを37℃にて
30分間反応させ、次いでアジ化ナトリウムを加え反応を
停止した。410nmを励起波長とし、550nmの蛍光強度を測
定した。その結果を表9に示す。
Example 9 100 mM phosphate buffer solution (pH 5.0) containing o-phenylenediamine at a concentration of 3 mg / ml was prepared with and without various condensed phosphorus oxoacid derivatives, and hydrogen peroxide was further reduced to 0.01%. In addition, a substrate reagent test solution was prepared. The substrate reagent test solution was dispensed into two 0.5 ml portions each, and 20 μl of a horseradish peroxidase-conjugated goat anti-mouse immunoglobulin antibody (manufactured by Kappel) at a concentration of 0.1 μg / ml was added to one, and to the other was added Did not. Each at 37 ° C
The reaction was allowed to proceed for 30 minutes, and then the reaction was stopped by adding sodium azide. Using the excitation wavelength at 410 nm, the fluorescence intensity at 550 nm was measured. Table 9 shows the results.

表9より、蛍光にて酵素活性を測定する検出系におい
ても、本発明の縮合燐オキソ酸誘導体を含有させた基質
試薬試液を用いた場合、含有させない基質試薬試液と比
べ、酵素反応がほとんど阻害されることなく非酵素的酸
化反応が抑制されることが明らかである。
From Table 9, it can be seen that even in the detection system for measuring the enzyme activity by fluorescence, when the substrate reagent TS containing the condensed phosphorus oxoacid derivative of the present invention was used, the enzyme reaction was almost inhibited as compared with the substrate reagent TS not containing the same. It is clear that the non-enzymatic oxidation reaction is suppressed without being performed.

実施例10 o−ジアニシジンを5mg/mlの濃度で含むジメチルスル
フォキシド3mlに各種濃度のトリポリ燐酸五ナトリウム
を含んだ50mMくえん酸−100mM燐酸緩衝液(pH4.9)12ml
を加え、更に過酸化水素を0.02%となる様に加え、基質
試薬試液とした。
Example 10 12 ml of 50 mM citric acid-100 mM phosphate buffer (pH 4.9) containing pentasodium tripolyphosphate at various concentrations in 3 ml of dimethyl sulfoxide containing o-dianisidine at a concentration of 5 mg / ml
Was added, and hydrogen peroxide was further added to a concentration of 0.02% to prepare a substrate reagent test solution.

基質試薬試液を2ml宛5本ずつに分注した後、1本に
は0.5μg/mlの濃度のホースラディッシュペルオキシダ
ーゼ結合ヤギ抗マウスイムノグロブリン抗体(カッペル
社製)100μを添加し、他の1本と共に37℃暗所にて
1時間反応させ、496nmにおける吸光度の差を酵素活性
とした。
After dispensing 5 ml of the substrate reagent solution into 2 ml aliquots, 100 μl of a horseradish peroxidase-conjugated goat anti-mouse immunoglobulin antibody (manufactured by Kappel) at a concentration of 0.5 μg / ml was added to each, and the other one was added. At 37 ° C. in a dark place for 1 hour, and the difference in absorbance at 496 nm was defined as the enzyme activity.

尚、酵素結合抗体を添加しないものはすべて吸光度は
0であった。残りの3本については室温、明所にて48時
間放置後、1本はそのまま吸光度を測定し、残りの2本
を用いて前記同様に酵素活性を測定を行った。
In addition, the absorbance was 0 in all cases where no enzyme-linked antibody was added. After leaving the remaining three tubes in a light place at room temperature for 48 hours, the absorbance of one was measured as it was, and the enzyme activity was measured in the same manner as described above using the remaining two tubes.

トリポリ燐酸五ナトリウム無添加の場合を対照とし相
対酵素活性を求めた。
Relative enzyme activity was determined using the case without pentasodium tripolyphosphate as a control.

その結果を表10に示す。 Table 10 shows the results.

表10より、基質としてo−ジアニシジンを用いた場合
においてもトリポリ燐酸五ナトリウムを約0.3から約30m
Mの範囲で添加することにより、酵素反応がほとんど阻
害されることなく非酵素的酸化反応が顕著に抑制され検
出系が安定すること、及び基質試薬試液の保存安定性が
明らかである。
From Table 10, even when o-dianisidine was used as the substrate, pentasodium tripolyphosphate was added in an amount of about 0.3 to about 30 m.
By adding in the range of M, it is clear that the non-enzymatic oxidation reaction is remarkably suppressed without substantially inhibiting the enzymatic reaction, the detection system is stabilized, and the storage stability of the substrate reagent test solution is apparent.

実施例11 縮合燐オキソ酸誘導体としてトリポリ燐酸五ナトリウ
ムの代りにテトラウルトラ燐酸二ナトリウムを用いたほ
かは実施例10と同様に行った。
Example 11 The same operation as in Example 10 was carried out except that disodium tetraultraphosphate was used instead of pentasodium tripolyphosphate as the condensed phosphorus oxoacid derivative.

その結果を表11に示す。 Table 11 shows the results.

表11より、基質としてo−ジアニシジンを用いた場合
においてもテトラウルトラ燐酸二ナトリウムを約0.3mM
から約50mMの範囲で用いることにより実施例10と同様の
効果が現れる。
From Table 11, even when o-dianisidine was used as the substrate, disodium tetraultraphosphate was added to about 0.3 mM.
The same effects as in Example 10 can be obtained by using in the range of from about 50 mM to about 50 mM.

尚添加量が100mMに及ぶと沈澱を生ずる。 If the amount added exceeds 100 mM, precipitation occurs.

実施例12 3,3′,5,5′−テトラメチルベンジジンを6mg/mlの濃
度で含むN−メチルピロリドン0.5mlに各種濃度のトリ
ポリ燐酸五ナトリウムを含む50mMくえん酸−100mM燐酸
緩衝液(pH4.9)3.5mlを加え、更に過酸化水素を0.02%
となる様に加え、基質試薬試液とした。基質試薬試液を
0.05ml宛5本ずつに分注した後、1本には0.5μg/mlの
濃度のホースラディッシュペルオキシダーゼ結合ヤギ抗
マウスイムノグロブリン抗体(カッペル社製)10μを
添加し、他の1本と共に37℃暗所にて30分間反応させた
1NH2SO42mlを加え、450nmにおける吸光度の差を酵素活
性とした。
Example 12 50 mM citric acid-100 mM phosphate buffer (pH 4) containing various concentrations of pentasodium tripolyphosphate in 0.5 ml of N-methylpyrrolidone containing 3,3 ', 5,5'-tetramethylbenzidine at a concentration of 6 mg / ml .9) Add 3.5 ml, and add 0.02% hydrogen peroxide
In addition, a substrate reagent test solution was prepared. Substrate reagent solution
After dispensing 5 bottles each to 0.05 ml, one of them was added with 10 μl of a horseradish peroxidase-conjugated goat anti-mouse immunoglobulin antibody (manufactured by Kappel) at a concentration of 0.5 μg / ml, and the other was incubated at 37 ° C. Allowed to react for 30 minutes in the dark
2 ml of 1NH 2 SO 4 was added, and the difference in absorbance at 450 nm was defined as the enzyme activity.

尚、酵素結合抗体を添加しないものはすべて吸光度は
0であった。残りの3本については室温、明所にて24時
間放置後、1本はそのまま吸光度を測定し、残りの2本
を用いて前記同様に酵素活性の測定を行った。トリポリ
燐酸五ナトリウム無添加の場合を対照として相対酵素活
性を求めた。
In addition, the absorbance was 0 in all cases where no enzyme-linked antibody was added. The remaining three tubes were allowed to stand at room temperature and in a light place for 24 hours, and the absorbance of one was measured as it was, and the enzyme activity of the other two tubes was measured in the same manner as described above. Relative enzyme activity was determined using a control without pentasodium tripolyphosphate as a control.

その経過を表12に示す。 The progress is shown in Table 12.

表12より基質として3,3′,5,5′テトラメチルベンジ
ジンを用いた場合においても、トリポリ燐酸五ナトリウ
ムを約1mMから約100mMの範囲で添加することにより、酵
素反応がほとんど阻害されることなく非酵素的酸化反応
が顕著に抑制され検出系が安定すること、及び基質試薬
試液の保存安定性が明きらかである。
According to Table 12, even when 3,3 ', 5,5'tetramethylbenzidine is used as the substrate, the enzyme reaction is almost inhibited by adding pentasodium tripolyphosphate in the range of about 1 mM to about 100 mM. Thus, the non-enzymatic oxidation reaction is remarkably suppressed and the detection system is stabilized, and the storage stability of the substrate reagent test solution is clear.

実施例13 縮合燐オキソ酸誘導体としてトリポリ燐酸五ナトリウ
ムの代りにヘキサメタ燐酸六ナトリウムを用いたほかは
実施例10と同様に行った。その結果を表13に示す。
Example 13 The same operation as in Example 10 was performed except that hexasodium hexametaphosphate was used instead of pentasodium tripolyphosphate as the condensed phosphorus oxoacid derivative. Table 13 shows the results.

表13より、基質として3,3′5,5′テトラメチルベンジ
ジンを用いた場合においてもヘキサメタ燐酸六ナトリウ
ムを約3mMから約100mMの範囲で用いることにより実施例
11と同様の効果が現れる。
From Table 13, it can be seen that even when 3,3'5,5'tetramethylbenzidine is used as a substrate, hexasodium hexametaphosphate is used in the range of about 3 mM to about 100 mM to give an example.
The same effect as 11 appears.

実施例14 種々の方法にて調製した基質試薬試液にて本発明の効
果を検討した。
Example 14 The effects of the present invention were examined using substrate reagent test solutions prepared by various methods.

方法 1 50mMくえん酸−100mM燐酸緩衝液(pH4.9)(以下試液
用緩衝液と称す)10mlにo−フェニレンジアミン30mgを
加え、更に縮合燐オキソ酸誘導体10mgを添加して完全に
溶解した。
Method 1 30 mg of o-phenylenediamine was added to 10 ml of a 50 mM citric acid-100 mM phosphate buffer (pH 4.9) (hereinafter referred to as a buffer for a test solution), and 10 mg of a condensed phosphorus oxoacid derivative was further added to completely dissolve.

次いで33%過酸化水素水を6μ加えて調製した。 Then, 6% of 33% aqueous hydrogen peroxide was added to prepare.

方法 2 試液用緩衝液10mlにo−フェニレンジアミン30mg、33
%過酸化水素水を6μ加え、更に縮合燐オキソ酸誘導
体10mgを加え調製した。
Method 2 O-phenylenediamine 30 mg, 33 ml
6% aqueous hydrogen peroxide was added, and 10 mg of a condensed phosphorus oxo acid derivative was further added.

方法 3 o−フェニレンジアミン30mgと縮合燐オキソ酸誘導体
10mgを純水3mlに溶解し、−20℃にて凍結後、減圧下に
凍結乾燥を行った。37℃にて1週間暗所に保存した後、
33%過酸化水素水6μを加えた試液用緩衝液10mlと混
和し調製した。
Method 3 30 mg of o-phenylenediamine and condensed phosphorus oxo acid derivative
10 mg was dissolved in 3 ml of pure water, frozen at −20 ° C., and lyophilized under reduced pressure. After storing in the dark at 37 ° C for one week,
It was prepared by mixing with 10 ml of a buffer solution for test solution to which 6 μm of 33% hydrogen peroxide solution was added.

方法 4 試液用緩衝液10mlに33%過酸化水素6μ及び縮合燐
オキソ酸誘導体10mgを加え37℃にて1週間暗所に保存し
た後、o−フェニレンジアミン30mgを加え調製した。
Method 4 To 10 ml of a buffer solution for the test solution, 6 μm of 33% hydrogen peroxide and 10 mg of a condensed phosphorus oxo acid derivative were added, and the mixture was stored at 37 ° C. for one week in a dark place, followed by addition of 30 mg of o-phenylenediamine.

方法 5 o−フェニレンジアミン30mgと縮合燐オキソ酸誘導体
5mgを純水3mlに溶解し、−20℃にて凍結後、減圧下に凍
結乾燥を行ない、37℃にて1週間暗所に保存した。試液
用緩衝液10mlに33%過酸化水素水6μ及び縮合燐オキ
ソ酸誘導体5mgを加え、同様に37℃にて1週間暗所に保
存した。両者を混和することにより調製した。
Method 5 30 mg of o-phenylenediamine and condensed phosphorus oxo acid derivative
5 mg was dissolved in 3 ml of pure water, frozen at −20 ° C., freeze-dried under reduced pressure, and stored at 37 ° C. for one week in a dark place. To 10 ml of the buffer for the test solution, 6 μm of 33% aqueous hydrogen peroxide and 5 mg of a condensed phosphorus oxoacid derivative were added, and the mixture was similarly stored at 37 ° C. for one week in a dark place. It was prepared by mixing both.

縮合燐オキソ酸誘導体としてトリポリ燐酸五ナトリウ
ム又はテトラウルトラ燐酸二ナトリウムを用いた。各々
の評価は実施例1と同様に行った。方法1において縮合
燐オキソ酸誘導体を加えないものについて比較例とし
た。
As a condensed phosphorus oxo acid derivative, pentasodium tripolyphosphate or disodium tetraultraphosphate was used. Each evaluation was performed in the same manner as in Example 1. In Comparative Example 1, a method in which a condensed phosphorus oxo acid derivative was not added in Method 1 was used.

結果を表14に示す。 Table 14 shows the results.

基質試薬試液調製時の縮合燐オキソ酸誘導体の添加の
順序にかかわらず、本発明の効果は明らかである。
The effects of the present invention are clear regardless of the order of addition of the condensed phosphorus oxoacid derivative during preparation of the substrate reagent test solution.

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】過酸化酵素に酸化されることにより解析手
段を与える基質及び3個以上の燐オキソ酸単位からなる
縮合燐オキソ酸誘導体を含有する基質試薬。
1. A substrate reagent comprising a substrate which provides an analysis means by being oxidized by a peroxidase and a condensed phosphorus oxo acid derivative comprising three or more phosphorus oxo acid units.
【請求項2】過酸化酵素又は擬似過酸化酵素、酸化され
ることにより解析手段を与える基質及び過酸化水素を用
いる検出系に於いて、3個以上の燐オキソ酸単位からな
る縮合燐オキソ酸誘導体を含有せしめる検出系の安定化
方法。
2. A condensed phosphorus oxo acid comprising three or more phosphorus oxo acid units in a peroxidase or pseudoperoxidase, a substrate that provides an analysis means by being oxidized, and a detection system using hydrogen peroxide. A method for stabilizing a detection system containing a derivative.
JP15520388A 1987-11-26 1988-06-22 Substrate reagent and method of stabilizing detection system Expired - Fee Related JP2759800B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP15520388A JP2759800B2 (en) 1987-11-26 1988-06-22 Substrate reagent and method of stabilizing detection system

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP29902287 1987-11-26
JP62-299022 1987-11-26
JP15520388A JP2759800B2 (en) 1987-11-26 1988-06-22 Substrate reagent and method of stabilizing detection system

Publications (2)

Publication Number Publication Date
JPH01243998A JPH01243998A (en) 1989-09-28
JP2759800B2 true JP2759800B2 (en) 1998-05-28

Family

ID=26483270

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15520388A Expired - Fee Related JP2759800B2 (en) 1987-11-26 1988-06-22 Substrate reagent and method of stabilizing detection system

Country Status (1)

Country Link
JP (1) JP2759800B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111024964A (en) * 2019-12-20 2020-04-17 深圳市蔚景生物科技有限公司 Composite quality control product for detecting stomach function and detection kit

Also Published As

Publication number Publication date
JPH01243998A (en) 1989-09-28

Similar Documents

Publication Publication Date Title
US4743561A (en) Luminescent assay with a reagent to alter transmitive properties of assay solution
Aebi Catalase
JP3159451B2 (en) Measurement of glycated protein
JPS5886083A (en) Stabilizing agent for glycerol-3-phosphoric acid oxidase
EP1477569B1 (en) Method of quantifying glycosylated protein using redox reaction and quantification kit
Fischer et al. Determination of the antioxidant capacity in blood.
EP1329722A1 (en) Assay method with the use of redox reaction
JP2759800B2 (en) Substrate reagent and method of stabilizing detection system
Hadwan et al. Seminal sulfhydryl oxidase: Appropriate fluorometric assay for the examination of spermatozoa disorders
JP2573009B2 (en) Stabilization method for substrate reagent solution
JP2003235600A (en) Liquid reagent for measuring free fatty acid (nefa)
EP1515143A1 (en) Method of assay by oxidation-reduction reaction with formazan
JP4542541B2 (en) Stabilized cholinesterase substrate solution
JPH0372280B2 (en)
JP3428073B2 (en) Determination of 1,5-anhydroglucitol
Kuan et al. An alternative method for the determination of uric acid in serum
JPH0919296A (en) Stabilization of chromophoric substrate, reagent, and quantification of microingredient
JP3415873B2 (en) Determination of 1,5-anhydroglucitol
JP2585723B2 (en) How to stop the reaction of the detection system
JP3690754B2 (en) Quantitative determination of components in samples
EP1452606A1 (en) Method for measurement using sodium azide
US5773303A (en) Process and kit to initiate a luminiferous reaction
JPH06237794A (en) Determination of 1,5-anhydroglucitol
JPH07265097A (en) Determination of iron
JP2663257B2 (en) Method for stabilizing reagent for measuring biological components

Legal Events

Date Code Title Description
S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees